Status:

COMPLETED

Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi

Lead Sponsor:

Liverpool School of Tropical Medicine

Collaborating Sponsors:

Kamuzu University of Health Sciences

London School of Hygiene and Tropical Medicine

Conditions:

HIV

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Despite increasing availability of antiretroviral therapy (ART) for HIV in high prevalence countries, the majority of people with HIV infection still initiate treatment at an advanced stage of disease...

Eligibility Criteria

Inclusion

  • Usual resident of an eligible cluster
  • Has had a positive HIV test (regardless of source) and requests facilitated access to HIV care from the resident community counsellor
  • Confirmatory HIV test is positive
  • No previous ART treatment, or less than one month's treatment in the past (including PMTCT interventions) and not currently receiving HIV care
  • No contraindications to receiving ART (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • No acute danger signs requiring hospital referral
  • Aged 18 years or older
  • Written or witnessed informed consent to participate in the study

Exclusion

  • Not a usual resident of an eligible cluster
  • No previous HIV test, or HIV infection not confirmed by home-based ART nurse
  • Already receiving ART, or has had more than 1 month's treatment in the past
  • Known contraindication to firstline ART (known hypersensitivity, renal failure, chronic liver disease)
  • Acute danger sign present (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • Age younger than 18 years
  • Not willing to accept home-based ART initiation
  • Suspected or confirmed TB disease will not be an exclusion criteria, but will be an indication for deferral, until completion of the screening algorithm, with initiation of TB treatment if indicated.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2013

Estimated Enrollment :

16660 Patients enrolled

Trial Details

Trial ID

NCT01414413

Start Date

January 1 2012

End Date

April 1 2013

Last Update

April 7 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

Blantyre, Chichiri, Malawi, 3